ANGO Angiodynamics Inc

Price (delayed)

$19.24

Market cap

$746.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.02

Enterprise value

$747.24M

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
The company's debt fell by 17% YoY
ANGO's gross profit is up by 12% year-on-year
ANGO's net income has surged by 77% year-on-year but it is down by 3.7% since the previous quarter
Angiodynamics's EPS has soared by 77% YoY but it has decreased by 4.1% from the previous quarter
The quick ratio has decreased by 24% YoY
Angiodynamics's equity has decreased by 6% YoY

Key stats

What are the main financial stats of ANGO
Market
Shares outstanding
38.78M
Market cap
$746.13M
Enterprise value
$747.24M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.73
Price to sales (P/S)
2.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.44
Earnings
Revenue
$306.06M
EBIT
-$44.48M
EBITDA
-$13.86M
Free cash flow
-$24.63M
Per share
EPS
-$1.02
Free cash flow per share
-$0.63
Book value per share
$11.1
Revenue per share
$7.83
TBVPS
$4.67
Balance sheet
Total assets
$543.18M
Total liabilities
$113.49M
Debt
$25M
Equity
$429.69M
Working capital
$78.32M
Liquidity
Debt to equity
0.06
Current ratio
2.59
Quick ratio
1.33
Net debt/EBITDA
-0.08
Margins
EBITDA margin
-4.5%
Gross margin
52.8%
Net margin
-13%
Operating margin
-13.8%
Efficiency
Return on assets
-7.2%
Return on equity
-9.2%
Return on invested capital
-36.6%
Return on capital employed
-9%
Return on sales
-14.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
-4.52%
1 week
2.89%
1 month
2.07%
1 year
-31.46%
YTD
-30.24%
QTD
-10.68%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$306.06M
Gross profit
$161.6M
Operating income
-$42.19M
Net income
-$39.75M
Gross margin
52.8%
Net margin
-13%
The company's operating margin has surged by 79% YoY but it fell by 3% QoQ
The company's net margin has surged by 79% YoY but it fell by 3.2% QoQ
ANGO's net income has surged by 77% year-on-year but it is down by 3.7% since the previous quarter
ANGO's operating income has soared by 77% year-on-year but it is down by 3.8% since the previous quarter

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
1.73
P/S
2.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.44
Angiodynamics's EPS has soared by 77% YoY but it has decreased by 4.1% from the previous quarter
The P/B is 24% more than the 5-year quarterly average of 1.4 but 21% less than the last 4 quarters average of 2.2
Angiodynamics's equity has decreased by 6% YoY
The P/S is 25% less than the last 4 quarters average of 3.3 and 9% less than the 5-year quarterly average of 2.7
The revenue has increased by 12% year-on-year

Efficiency

How efficient is Angiodynamics business performance
Angiodynamics's ROS has soared by 77% YoY but it has decreased by 2.8% from the previous quarter
The ROE has soared by 75% year-on-year but it is down by 6% since the previous quarter
ANGO's ROA has soared by 75% year-on-year but it is down by 6% since the previous quarter
ANGO's ROIC has soared by 72% YoY

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
The quick ratio has decreased by 24% YoY
ANGO's current ratio is down by 11% year-on-year but it is up by 7% since the previous quarter
The company's debt is 94% lower than its equity
The company's debt fell by 17% YoY
The debt to equity has contracted by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.